Published in Gene Therapy Weekly, October 12th, 2006
"IL-2 used in the treatment of malignant tumors has an anti-tumor efficacy. In this study, we have studied in vitro characterization and transfection efficiency of a plasmid encoding hIL-2, pCXWN-hIL-2, complexed to chitosan, polyethylenimine or DOTAP with varying ratios," wrote G. Ozgel and colleagues, University of Marmara.
"Plasmid DNA was amplified in Escherichia coli DH5 alpha and isolated by alkali lysis method. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.